Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr

The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside

India's clinical research ambitions need more than regulatory reforms: Experts

At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust

Health Ministry proposes faster licensing timelines for medical device manufacturers

The proposed changes seek to shorten the statutory timelines for granting manufacturing licences across various risk categories

India to launch revamped Anemia Mukt Bharat Abhiyaan with expanded 7x7x7 strategy

The transition of the existing Anemia Mukt Bharat programme into Anemia Mukt Bharat Abhiyaan signals a shift towards a more comprehensive, technology-enabled and community-driven approach

Diabetes driving surge in early cataracts among Indians in 40s & 50s

India is home to more than 101 million adults living with diabetes and another 136 million with prediabetes

Johnson & Johnson launches first-in-human SKYWARD trial for carotid IVL system

Carotid artery disease accounts for up to 30% of all strokes

Efzimfotase alfa shows strong Phase III results in pediatric hypophosphatasia trial

The study also met its key secondary endpoint for bone health

Sanofi Foundation doubles down on children and youth with €15 milliion annual push

The Foundation says it is working alongside NGOs, healthcare professionals, patient groups, and local communities to build programs

PeptiStar tests Asahi Kasei’s heat-free system to speed up API manufacturing

Otsuka reports strong Phase 3b results for centanafadine XR in adults with ADHD

The investigational treatment is showing statistically significant improvements in ADHD symptoms versus placebo at week 8